Gilead Sciences
Search results
Amgen is a biotech company that develops and delivers innovative medicines for serious illnesses. Learn about Amgen's science, innovation, responsibility, and latest news and stories.
- About
Amgen harnesses the best of biology and technology to fight...
- Science
Amgen is a pioneer in the science of using living cells to...
- PRODUCTS
Amgen’s medicines treat serious illnesses and typically...
- Responsibility
Our ESG Framework . Amgen’s ESG framework is built on four...
- Stories
From the Office to the Lab, Amgen Uses AI Tools to Unlock...
- Newsroom
While vaccines offer promise in the future, patients with...
- Partners
Amgen is committed to partnering with innovators in the...
- Amgen Worldwide
At Amgen, we are committed to the relentless pursuit of...
- About
Footnotes / references. [1] [2] Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. [3] [4] One of the world's largest independent biotechnology companies, As of 2022, Amgen has approximately 24,000 staff in total.
YOU ARE NOW LEAVING AMGEN MALAYSIA'S WEBSITE. Amgen Malaysia takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.
A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options. With a presence in approximately 100 countries, we are proud to have reached millions of people with our products.
At Amgen, we are committed to the relentless pursuit of breakthroughs for cancer patients and their families. We have a deep and diverse pipeline of cutting-edge therapeutic approaches that aim to improve outcomes.
A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
